Work

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

Year: 2019

Type: erratum

Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Source: Nature Communications

DOI: 10.1038/s41467-019-13151-z

Authors: Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, Brennan Olson, Katherine R. Pelz, Diana M. Angeles Ramos, H. Carlo Maurer, Kenneth P. Olive, Lisa M. Coussens, Terry K. Morgan, Daniel L. Marks

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Columbia University Irving Medical Center, Columbia University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $5,200

Funder: National Cancer Institute

Awards: G1797368095, G4612109389, G642207974

OpenAlex ID: W2983235264

Cites:

Cited by: 14

Related to: 10